Trinity Biotech (TRIB) Capital Leases (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Capital Leases for 9 consecutive years, with $10.5 million as the latest value for Q4 2024.
- Quarterly Capital Leases fell 3.63% to $10.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $10.5 million through Dec 2024, down 3.63% year-over-year, with the annual reading at $10.5 million for FY2024, 3.63% down from the prior year.
- Capital Leases hit $10.5 million in Q4 2024 for Trinity Biotech, down from $10.9 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $16.6 million in Q4 2020 to a low of $10.5 million in Q4 2024.
- Historically, Capital Leases has averaged $12.8 million across 5 years, with a median of $12.3 million in 2022.
- Biggest five-year swings in Capital Leases: dropped 16.42% in 2021 and later fell 3.63% in 2024.
- Year by year, Capital Leases stood at $16.6 million in 2020, then dropped by 16.42% to $13.9 million in 2021, then dropped by 11.53% to $12.3 million in 2022, then dropped by 11.37% to $10.9 million in 2023, then decreased by 3.63% to $10.5 million in 2024.
- Business Quant data shows Capital Leases for TRIB at $10.5 million in Q4 2024, $10.9 million in Q4 2023, and $12.3 million in Q4 2022.